RxDoctor Payments Data

John Brooks, MD

Emergency Medical Services · Jackson, MSNPI 1023046711

Payments from drug & device makers

What this record shows

8 manufacturers reported payments, led by Welch Allyn at 51.9% of the total. Reporting peaked in 2021 at $457 and has fallen 85.7% since, to $65 in 2025. Among emergency medical services clinicians in MS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$708in general payments, 2019–2025

Across 22 payments — averaging $32.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Welch Allyn$368
  • Johnson & Johnson$164
  • Pfizer$65
  • Inari Medical, Inc.$45
  • CSL Behring$23
  • AstraZeneca$16
  • plus $27 from 2 others

What the payments were for

  • Food & beverage$34048%
  • Other$36852%

General payments by program year

19
20
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$708 in reported general payments places this provider in the 90th percentile of 25 emergency medical services providers in Mississippi.

See all emergency medical services providers in Mississippi

Medicare billing

Part B allowed, 2024
$122,438
Medicare patients
625
Services billed
2,273

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban22$13,843
Cefdinir46$753
Sucralfate11$370
Doxycycline Hyclate39$346
Pantoprazole Sodium28$331
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst23$326
Albuterol Sulfate HfaAlbuterol Sulfate15$310
Gabapentin13$277
Potassium Chloride17$249
Losartan Potassium21$245
Azithromycin55$244
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav28$241
Diclofenac Sodium12$208
Metformin Hcl34$196
Escitalopram Oxalate15$192

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$65$13,84322 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 25 emergency medical services providers in Mississippi.

Other emergency medical services in Jackson

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →